Related Experiment Video
Updated: Apr 23, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
N-Acetylcysteine treatment of rotavirus-associated diarrhea in children
Carlos A Guerrero1, Diana P Torres, Leidy L García
1Department of Physiological Sciences, Faculty of Medicine, Universidad Nacional de Colombia, Bogota, D.C, Colombia.
Insights
N-acetylcysteine (NAC) effectively treated rotavirus diarrhea in young children. NAC administration reduced symptoms and viral shedding, offering a potential complementary strategy for managing this common childhood illness.
Area of Science:
- Pediatrics
- Virology
- Gastroenterology
Background:
- Rotaviruses are a primary cause of severe diarrhea in children globally.
- Existing rotavirus vaccines have reduced mortality, but alternative treatments are still needed, especially in resource-limited settings.
Observation:
- Five unvaccinated children (four 12-13 months old, one 5 years old) presented with rotavirus-associated diarrhea.
- Three children received oral N-acetylcysteine (NAC) 60 mg/kg daily after the first diarrheal day; two served as controls.
Findings:
- NAC treatment led to fewer diarrheal episodes and reduced fecal rotavirus antigen excretion.
- Symptoms resolved within 2 days in children treated with NAC.
Implications:
- N-acetylcysteine (NAC) shows promise as an efficient treatment for rotavirus-associated diarrhea in children.
- NAC may help prevent severe dehydration, a life-threatening complication of rotavirus infection.
Abstract:
Rotaviruses are the leading cause of severe, acute, and dehydrating diarrhea affecting children under 5 years of age worldwide. Despite an important reduction in rotavirus-caused deaths as a consequence of the rotavirus vaccine, alternative or complementary strategies for preventing or treating rotavirus-associated diarrhea are needed mainly in the poorest countries. We describe the cases of four rotavirus-unvaccinated 12-13-month-old girls and a 5-year-old boy who developed rotavirus-associated diarrhea confirmed by enzyme-linked immunosorbent assay, Western blotting, and immunochemistry analyses. After the first day of diarrheal episodes, three of the five patients were immediately administered oral N-acetylcysteine (NAC) 60 mg/kg daily, divided into three equal doses every 8 hours. The other two patients did not receive NAC and served as controls. Administration of NAC resulted in a decreased number of diarrheal episodes, excretion of fecal rotavirus antigen, and resolution of symptoms after 2 days of treatment. Our results suggest that NAC treatment after the first diarrheal episode could be an efficient strategy for treating rotavirus-affected children and preventing the associated severe life-threatening accompanying dehydration.
More Related Videos
Related Concept Videos
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Prevention of Further Absorption of Poison
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Pharmaceutical Poisoning: Treatment Strategies

